Notice of application.
Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration in accordance with 21 CFR 1301.33(a) on or before October 17, 2016.
Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/ODW, 8701 Morrissette Drive, Springfield, Virginia 22152.
Start Supplemental Information
The Attorney General has delegated her authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Deputy Assistant Administrator of the DEA Office of Diversion Control (“Deputy Assistant Administrator”) pursuant to section 7 of 28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR 1301.33(a), this is notice that on May 5, 2016, Chemtos, LLC, 14101 W. Highway 290, Building 2000B, Austin, Texas 78737-9331 applied to be registered as a bulk manufacturer for the following basic classes of controlled substances:
|Etorphine HCI (9059)||II|
|Meperidine intermediate-A (9232)||II|
|Meperidine intermediate-B (9233)||II|
|Meperidine intermediate-C (9234)||II|
|Methadone intermediate (9254)||II|
The company plans to manufacture small quantities of the listed controlled substances in bulk for distribution to its customers for use as reference standards.
End Supplemental Information
Louis J. Milione,
Deputy Assistant Administrator.
[FR Doc. 2016-19449 Filed 8-15-16; 8:45 am]
BILLING CODE 4410-09-P